Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A choreography of centrosomal mRNAs reveals a conserved localization mechanism involving active polysome transport. | Nat Commun | 2021 | 33649340 | PubTator, text mining | PubMed |
| Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma. | BMC Cancer | 2021 | 33648465 | PubTator, text mining | PubMed |
| Hydrogel-Supported, Engineered Model of Vocal Fold Epithelium. | ACS Biomater Sci Eng | 2021 | 33635635 | PubTator, text mining | PubMed |
| Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. | Biomed Res Int | 2021 | 33628816 | PubTator, text mining | PubMed |
| Competing endogenous RNAs in lung cancer. | Cancer Biol Med | 2021 | 33628581 | PubTator, text mining | PubMed |
| Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression. | Aging (Albany NY) | 2021 | 33619234 | PubTator, text mining | PubMed |
| Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors. | Front Pharmacol | 2021 | 33613290 | PubTator, text mining | PubMed |
| Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer. | Technol Cancer Res Treat | 2021 | 33596783 | PubTator, text mining | PubMed |
| Comprehensive analysis of macrophage-related multigene signature in the tumor microenvironment of head and neck squamous cancer. | Aging (Albany NY) | 2021 | 33592580 | PubTator, text mining | PubMed |
| Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy. | J Immunother Cancer | 2021 | 33589525 | PubTator, text mining | PubMed |
| PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung. | Cancer Immunol Immunother | 2021 | 33576873 | PubTator, text mining | PubMed |
| Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker. | Oncol Lett | 2021 | 33574944 | PubTator, text mining | PubMed |
| A Closer Look at the Cellular and Molecular Components of the Deep/Muscular Fasciae. | Int J Mol Sci | 2021 | 33573365 | PubTator, text mining | PubMed |
| Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. | Cell | 2021 | 33571429 | PubTator, text mining | PubMed |
| A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside. | Transl Lung Cancer Res | 2021 | 33569302 | PubTator, text mining | PubMed |
| Systematic transcriptome-based comparison of cellular adaptive stress response activation networks in hepatic stem cell-derived progeny and primary human hepatocytes. | Toxicol In Vitro | 2021 | 33545341 | PubTator, text mining | PubMed |
| Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival. | Int J Mol Sci | 2021 | 33540684 | PubTator, text mining | PubMed |
| CD44 and Tumor-Derived Extracellular Vesicles (TEVs). Possible Gateway to Cancer Metastasis. | Int J Mol Sci | 2021 | 33540535 | PubTator, text mining | PubMed |
| Hyaluronic acid-doxorubicin nanoparticles for targeted treatment of colorectal cancer. | Bioeng Transl Med | 2021 | 33532580 | PubTator, text mining | PubMed |
| Integrative bioinformatics approaches for identifying potential biomarkers and pathways involved in non-obstructive azoospermia. | Transl Androl Urol | 2021 | 33532314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=44